Saul Lema Asqui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saul Lema Asqui has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Nuria Sanchez Coll
Centre for Research in Agricultural Genomics (CRAG), CSIC‐IRTA‐UAB‐UB, Campus UAB Bellaterra Spain
2 shared publications - Amit Kumar Bajhaiya
Central University of Tamil Nadu
1 shared publication - Christiane Funk
Umeå University
1 shared publication Dominique Vercammen
Department of Plant Systems Biology, VIB, Ghent, 9052, Belgium
1 shared publication- Evy Timmerman
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
1 shared publication - Francis Impens
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
1 shared publication
Latest Publications
- Open Access
- 13 October 2025
- Published by Esprint in Esprint Investigación
- Vol. 4 (3) , 219-233
Análisis temporal del microbioma clínico y su relación con patrones de resistencia antimicrobiana en el Hospital Carlos Andrade Marín (2018–2024)
La resistencia antimicrobiana constituye una de las principales amenazas para la salud pública y su dinámica está estrechamente vinculada a los cambios en el microbioma clínico. El objetivo de este estudio fue analizar la variabilidad temporal del microbioma clínico y su relación con los patrones de resistencia antimicrobiana durante el período 2018–2024. Se realizó un estudio retrospectivo y observacional basado en datos microbiológicos provenientes de cultivos clínicos procesados en un hospital de referencia. Se caracterizó la distribución anual de microorganismos y se evaluaron los perfiles de sensibilidad y resistencia para antibióticos de primera y segunda línea. Adicionalmente, se aplicaron modelos de series temporales para identificar tendencias, estacionalidad y posibles cambios estructurales en la dinámica microbiana. Los resultados evidencian variaciones significativas en la prevalencia de microorganismos, con incrementos estacionales en agentes Gram negativos y fluctuaciones en la resistencia a antimicrobianos críticos. El análisis temporal permitió identificar patrones emergentes de resistencia con implicaciones directas para la toma de decisiones terapéuticas. Este estudio aporta evidencia clave para fortalecer la vigilancia microbiológica y orientar estrategias de uso racional de antibióticos.
- 13 October 2025
- Published by Esprint in Esprint Investigación
- Vol. 4 (3) , 219-233
Open AccessAnálisis temporal del microbioma clínico y su relación con patrones de resistencia antimicrobiana en el Hospital Carlos Andrade Marín (2018–2024)
La resistencia antimicrobiana constituye una de las principales amenazas para la salud pública y su dinámica está estrechamente vinculada a los cambios en el microbioma clínico. El objetivo de este estudio fue analizar la variabilidad temporal del microbioma clínico y su relación con los patrones de resistencia antimicrobiana durante el período 2018–2024. Se realizó un estudio retrospectivo y observacional basado en datos microbiológicos provenientes de cultivos clínicos procesados en un hospital de referencia. Se caracterizó la distribución anual de microorganismos y se evaluaron los perfiles de sensibilidad y resistencia para antibióticos de primera y segunda línea. Adicionalmente, se aplicaron modelos de series temporales para identificar tendencias, estacionalidad y posibles cambios estructurales en la dinámica microbiana. Los resultados evidencian variaciones significativas en la prevalencia de microorganismos, con incrementos estacionales en agentes Gram negativos y fluctuaciones en la resistencia a antimicrobianos críticos. El análisis temporal permitió identificar patrones emergentes de resistencia con implicaciones directas para la toma de decisiones terapéuticas. Este estudio aporta evidencia clave para fortalecer la vigilancia microbiológica y orientar estrategias de uso racional de antibióticos.
- Open Access
- 13 October 2025
- Published by Esprint in Esprint Investigación
- Vol. 4 (3) , 141-156
Impacto de la cobertura de vacunación masiva contra la fiebre amarilla en la prevención y control de brotes en Ecuador: análisis espacio-temporal 2021-2024
La fiebre amarilla continúa representando un riesgo epidemiológico para los países de la región amazónica. Aunque Ecuador no ha registrado brotes recientes, la circulación viral en zonas fronterizas, la presencia del vector y la movilidad humana sostienen un riesgo latente que exige vigilancia permanente. La vacunación masiva constituye la principal estrategia para prevenir brotes y mitigar impactos sanitarios y económicos. Este estudio evaluó el impacto de las coberturas de vacunación contra la fiebre amarilla en Ecuador mediante un análisis espacio–temporal del periodo 2021–2024. Se aplicó enfoque mixto con un diseño observacional retrospectivo. A partir de registros oficiales del Ministerio de Salud Pública, se realizaron análisis descriptivos, series temporales, descomposición estacional, modelos ARIMA y evaluación geoespacial con SIG. El componente cualitativo se basó en lineamientos de la OPS/OMS y normativa nacional sobre vigilancia y control. Durante los cuatro años analizados se administraron más de 903 025 dosis. La tendencia nacional mostró fluctuaciones, con un incremento sostenido hasta 2023 y posterior estabilización en 2024. Guayas, Los Ríos y Manabí concentraron la mayor actividad vacunal, mientras que las provincias amazónicas presentaron coberturas menores pese a su alto riesgo ecológico. El análisis estacional identificó picos de actividad entre febrero y abril. El modelo ARIMA mostró un ajuste adecuado y proyectó estabilidad moderada para 2025–2026. El análisis geográfico reveló un patrón Costa–Sierra–Amazonía con desigualdades territoriales marcadas. Se concluye que la vacunación contra la fiebre amarilla en Ecuador presenta importantes brechas espaciales y temporales, lo que demanda fortalecer la cobertura en la región amazónica.
- 13 October 2025
- Published by Esprint in Esprint Investigación
- Vol. 4 (3) , 141-156
Open AccessImpacto de la cobertura de vacunación masiva contra la fiebre amarilla en la prevención y control de brotes en Ecuador: análisis espacio-temporal 2021-2024
La fiebre amarilla continúa representando un riesgo epidemiológico para los países de la región amazónica. Aunque Ecuador no ha registrado brotes recientes, la circulación viral en zonas fronterizas, la presencia del vector y la movilidad humana sostienen un riesgo latente que exige vigilancia permanente. La vacunación masiva constituye la principal estrategia para prevenir brotes y mitigar impactos sanitarios y económicos. Este estudio evaluó el impacto de las coberturas de vacunación contra la fiebre amarilla en Ecuador mediante un análisis espacio–temporal del periodo 2021–2024. Se aplicó enfoque mixto con un diseño observacional retrospectivo. A partir de registros oficiales del Ministerio de Salud Pública, se realizaron análisis descriptivos, series temporales, descomposición estacional, modelos ARIMA y evaluación geoespacial con SIG. El componente cualitativo se basó en lineamientos de la OPS/OMS y normativa nacional sobre vigilancia y control. Durante los cuatro años analizados se administraron más de 903 025 dosis. La tendencia nacional mostró fluctuaciones, con un incremento sostenido hasta 2023 y posterior estabilización en 2024. Guayas, Los Ríos y Manabí concentraron la mayor actividad vacunal, mientras que las provincias amazónicas presentaron coberturas menores pese a su alto riesgo ecológico. El análisis estacional identificó picos de actividad entre febrero y abril. El modelo ARIMA mostró un ajuste adecuado y proyectó estabilidad moderada para 2025–2026. El análisis geográfico reveló un patrón Costa–Sierra–Amazonía con desigualdades territoriales marcadas. Se concluye que la vacunación contra la fiebre amarilla en Ecuador presenta importantes brechas espaciales y temporales, lo que demanda fortalecer la cobertura en la región amazónica.
- Open Access
- 1 May 2024
- Published by Wiley in Physiologia Plantarum
- Vol. 176 (3) , e14401
In vivo proteolytic profiling of the type I and type II metacaspases in Chlamydomonas reinhardtii exposed to salt stress
Metacaspases are cysteine proteases present in plants, fungi and protists. While the association of metacaspases with cell death is studied in a range of organisms, their native substrates are largely unknown. Here, we explored the in vivo proteolytic landscape of the two metacaspases, CrMCA‐I and CrMCA‐II, present in the green freshwater alga Chlamydomonas reinhardtii, using mass spectrometry‐based degradomics approach, during control conditions and salt stress. Comparison between the cleavage events of CrMCA‐I and CrMCA‐II in metacaspase mutants revealed unique cleavage preferences and substrate specificity. Degradome analysis demonstrated the relevance of the predicted metacaspase substrates to the physiology of C. reinhardtii cells and its adaptation during salt stress. Functional enrichment analysis indicated an involvement of CrMCA‐I in the catabolism of carboxylic acids, while CrMCA‐II plays an important role in photosynthesis and translation. Altogether, our findings suggest distinct cellular functions of the two metacaspases in C. reinhardtii during salt stress response.
- 1 May 2024
- Published by Wiley in Physiologia Plantarum
- Vol. 176 (3) , e14401
Open AccessIn vivo proteolytic profiling of the type I and type II metacaspases in Chlamydomonas reinhardtii exposed to salt stress
Metacaspases are cysteine proteases present in plants, fungi and protists. While the association of metacaspases with cell death is studied in a range of organisms, their native substrates are largely unknown. Here, we explored the in vivo proteolytic landscape of the two metacaspases, CrMCA‐I and CrMCA‐II, present in the green freshwater alga Chlamydomonas reinhardtii, using mass spectrometry‐based degradomics approach, during control conditions and salt stress. Comparison between the cleavage events of CrMCA‐I and CrMCA‐II in metacaspase mutants revealed unique cleavage preferences and substrate specificity. Degradome analysis demonstrated the relevance of the predicted metacaspase substrates to the physiology of C. reinhardtii cells and its adaptation during salt stress. Functional enrichment analysis indicated an involvement of CrMCA‐I in the catabolism of carboxylic acids, while CrMCA‐II plays an important role in photosynthesis and translation. Altogether, our findings suggest distinct cellular functions of the two metacaspases in C. reinhardtii during salt stress response.
- 3 February 2017
- Published by Wiley in New Phytologist
- Vol. 218 (3) , 1156-1166
AtSERPIN1 is an inhibitor of the metacaspase AtMC1‐mediated cell death and autocatalytic processing in planta
Summary: The hypersensitive response (HR) is a localized programmed cell death phenomenon that occurs in response to pathogen recognition at the site of attempted invasion. Despite more than a century of research on HR, little is known about how it is so tightly regulated and how it can be contained spatially to a few cells. AtMC1 is an Arabidopsis thaliana plant metacaspase that positively regulates the HR. Here, we used an unbiased approach to identify new AtMC1 regulators. Immunoaffinity purification of AtMC1‐containing complexes led us to the identification of the protease inhibitor AtSerpin1. Our data clearly showed that coimmunoprecipitation between AtMC1 and AtSerpin1 and formation of a complex between them was lost upon mutation of the AtMC1 catalytic site, and that the AtMC1 prodomain was not required for the interaction. AtSerpin1 blocked AtMC1 self‐processing and inhibited AtMC1‐mediated cell death. Our results constitute an in vivo example of a Serpin acting as a suicide inhibitor in plants, reminiscent of the activity of animal or viral serpins on immune/cell death regulators, including caspase‐1. These results indicate a conserved function of a protease inhibitor on cell death regulators from different kingdoms with unrelated modes of action (i.e. caspases vs metacaspases).
- 3 February 2017
- Published by Wiley in New Phytologist
- Vol. 218 (3) , 1156-1166
AtSERPIN1 is an inhibitor of the metacaspase AtMC1‐mediated cell death and autocatalytic processing in planta
Summary: The hypersensitive response (HR) is a localized programmed cell death phenomenon that occurs in response to pathogen recognition at the site of attempted invasion. Despite more than a century of research on HR, little is known about how it is so tightly regulated and how it can be contained spatially to a few cells. AtMC1 is an Arabidopsis thaliana plant metacaspase that positively regulates the HR. Here, we used an unbiased approach to identify new AtMC1 regulators. Immunoaffinity purification of AtMC1‐containing complexes led us to the identification of the protease inhibitor AtSerpin1. Our data clearly showed that coimmunoprecipitation between AtMC1 and AtSerpin1 and formation of a complex between them was lost upon mutation of the AtMC1 catalytic site, and that the AtMC1 prodomain was not required for the interaction. AtSerpin1 blocked AtMC1 self‐processing and inhibited AtMC1‐mediated cell death. Our results constitute an in vivo example of a Serpin acting as a suicide inhibitor in plants, reminiscent of the activity of animal or viral serpins on immune/cell death regulators, including caspase‐1. These results indicate a conserved function of a protease inhibitor on cell death regulators from different kingdoms with unrelated modes of action (i.e. caspases vs metacaspases).
- 18 July 2016
- Published by Springer Nature
- Vol. 1450, 195-203
Detection and Quantification of Protein Aggregates in Plants
Plants are constantly exposed to a complex and changing environment that challenges their cellular homeostasis. Stress responses triggered as a consequence of unfavorable conditions result in increased protein aggregate formation at the cellular level. When the formation of misfolded proteins surpasses the capacity of the cell to remove them, insoluble protein aggregates accumulate. In the animal field, an enormous effort is being placed to uncover the mechanisms regulating aggregate formation because of its implications in many important human diseases. Because of its importance for cellular functionality and fitness, it is equally important to expand plant research in this field. Here, we describe a cell fractionation-based method to obtain very pure insoluble protein aggregate fractions that can be subsequently semiquantified using image analysis. This method can be used as a first step to evaluate whether a particular condition results in an alteration of protein aggregate formation levels.
- 18 July 2016
- Published by Springer Nature
- Vol. 1450, 195-203
Detection and Quantification of Protein Aggregates in Plants
Plants are constantly exposed to a complex and changing environment that challenges their cellular homeostasis. Stress responses triggered as a consequence of unfavorable conditions result in increased protein aggregate formation at the cellular level. When the formation of misfolded proteins surpasses the capacity of the cell to remove them, insoluble protein aggregates accumulate. In the animal field, an enormous effort is being placed to uncover the mechanisms regulating aggregate formation because of its implications in many important human diseases. Because of its importance for cellular functionality and fitness, it is equally important to expand plant research in this field. Here, we describe a cell fractionation-based method to obtain very pure insoluble protein aggregate fractions that can be subsequently semiquantified using image analysis. This method can be used as a first step to evaluate whether a particular condition results in an alteration of protein aggregate formation levels.